Influence of Gut Microbiota and its Metabolites on Progression of Metabolic Associated Fatty Liver Disease / 中国医学科学杂志(英文版)
Chinese Medical Sciences Journal
; (4): 286-296, 2023.
Article
in English
| WPRIM (Western Pacific)
| ID: wpr-1009000
Responsible library:
WPRO
ABSTRACT
Metabolic associated fatty liver disease (MAFLD) has become a prevalent chronic liver disease worldwide because of lifestyle and dietary changes. Gut microbiota and its metabolites have been shown to play a critical role in the pathogenesis of MAFLD. Understanding of the function of gut microbiota and its metabolites in MAFLD may help to elucidate pathological mechanisms, identify diagnostic markers, and develop drugs or probiotics for the treatment of MAFLD. Here we review the pathogenesis of MAFLD by gut microbiota and its metabolites and discuss the feasibility of treating MAFLD from the perspective of gut microbes.
Full text:
Available
Database:
WPRIM (Western Pacific)
Main subject:
Fatty Liver
/
Gastrointestinal Microbiome
Limits:
Humans
Language:
English
Journal:
Chinese Medical Sciences Journal
Year:
2023
Document type:
Article